Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNostrum Oil&gas Regulatory News (NOG)

Share Price Information for Nostrum Oil&gas (NOG)

Share Price is delayed by 15 minutes
Get Live Data
3.50    0.00 (0.00%)
Bid:
3.00
Ask:
4.00
Spread: 1.00 (33.333%)
Market Cap: £5.77m
NOG Live PriceLast checked at - London Stock Exchange

Intraday Nostrum Oil&gas Share Chart

ANNOUNCEMENT OF ADJOURNMENT

12 Dec 2023 10:12

RNS Number : 4987W
Nostrum Oil & Gas PLC
12 December 2023

USD $250,000,000 5.00% Senior Secured Notes due 2026

Reg S: CUSIP: N64884AF1 / ISIN: USN64884AF16Private Placement: CUSIP: 66978CAF9 / ISIN: US66978CAF95

issued pursuant to a trust deed dated 9 February 2023

and

?

USD $362,648,402 1.00%/13.00% Senior Unsecured Notes due 2026

Reg S: CUSIP: N64884AE4 / ISIN: USN64884AE41Private Placement: CUSIP: 66978CAD4 / ISIN: US66978CAD48

issued pursuant to a trust deed dated 9 February 2023

of

Nostrum Oil & Gas Finance B.V.

incorporated under the laws of the Netherlands

ANNOUNCEMENT OF ADJOURNMENT

FOR THE CONSENT SOLICITATION IN RESPECT OF CERTAIN OUTSTANDING NOTES ISSUED BY Nostrum Oil & Gas Finance B.V. AND WARRANTS ISSUED BY NOSTRUM OIL & GAS PLC

London and the Netherlands, 12 December 2023 - Nostrum Oil & Gas Finance B.V. (the "Issuer"), a wholly-owned subsidiary of Nostrum Oil & Gas PLC (the "Parent"), announced on 21 November 2023 that it had commenced a consent solicitation (the "Consent Solicitation") in respect of its USD $250,000,000 5.00% Senior Secured Notes due 2026 (the "Senior Secured Notes") and USD $362,648,402 1.00%/13.00% Senior Unsecured Notes due 2026 (the "Senior Unsecured Notes", and together with the Senior Secured Notes, the "Notes"). Meetings of the holders of the Notes were held on 12 December 2023 (the "Meetings") for the purpose of considering and, if thought fit, approving the extraordinary resolutions that are the subject of the proposal being duly passed (the "Extraordinary Resolutions") set out in the consent solicitation memorandum dated 20 November 2023 (the "Consent Solicitation Memorandum"). The requisite quorum at each Meeting was not present and the Meetings were adjourned by the chair for a period not less than 7 nor more than 42 days in accordance with the terms of the trust deeds governing the Notes (the "Trust Deeds"). The deadline for Noteholders to deliver or procure delivery of a form of proxy to the Information and Tabulation Agent is 15 December 2023 (the "Adjourned Meeting Deadline").

The Issuer is soliciting the consents of the holders of the Notes and the warrants issued by the Parent (the "Warrants") (together the "Noteholders") for certain amendments to the Trust Deeds, the debenture dated 9 February 2023 relating to the Notes and the share warrant instrument dated 9 February 2023 (the "Warrant Instrument") in order to (i) to permit the investment of cash from the Parent into certain investment products approved by the board of directors of the Parent in order to give the Issuer greater flexibility to make investments in cash equivalents to receive higher returns and (ii) amend the Warrant Instrument such that the Parent would not require further consent from the warrant holders to delist its shares from the Astana International Exchange (AIX).

The terms and conditions of the Consent Solicitation are as set forth in the Consent Solicitation Memorandum distributed to all Noteholders. The Consent Solicitation Memorandum was made available to the Noteholders by GLAS Trust Company LLC, the Information and Tabulation Agent for the Consent Solicitation.

Condition to the Proposal

The consummation of the Consent Solicitation is conditional upon the approval of the Extraordinary Resolutions at each relevant adjourned meeting of Noteholders (each, an "Adjourned Meeting").

A Noteholder may vote in relation to the Consent Solicitation by submitting consent to The Depository Trust Company (the "Clearing System") in accordance with the requirements of the Clearing System. For the avoidance of doubt, the holders of the Senior Unsecured Notes are the ultimate beneficial holders of the Warrants. Therefore, votes by holders of the Senior Unsecured Notes to the proposed amendments will be a vote with respect to both of the Senior Unsecured Notes and the Warrants that they hold.

Each person who is shown in the records of DTC as a holder of the Notes wishing to submit a form of proxy must complete, sign and date the form of proxy in accordance with the instructions set forth herein and therein, and send a PDF version of the form of proxy by email to USReorg@GLAS.AGENCY.

By submitting a Consent Instruction prior to the Adjourned Meeting Deadline, each Noteholder will appoint one or more representatives of the Information and Tabulation Agent as its proxy to attend the Adjourned Meetings on its behalf and to vote in the manner specified or identified in such Consent Instruction in respect of the Extraordinary Resolutions.

Alternatively, Noteholders who wish to attend and vote at the Adjourned Meetings should contact the Information and Tabulation Agent to make arrangements for their attendance.

The Global Note certificate in respect of the Notes is deposited with a custodian for DTC and registered in the name of Cede & Co. as nominee. Each person who is the owner of a particular nominal amount of the Notes through the Clearing Systems or their respective accountholders, should note that such person will not be a Noteholder for the purposes of attending and voting at, or establishing the quorum for, the relevant Meeting and will only be entitled to attend and vote at the relevant Meeting or appoint a proxy to do so in accordance with the procedures set out below.

Meetings

The Adjourned Meetings are to be held at the offices of White & Case LLP, 5 Old Broad Street, London EC2N 1DW, United Kingdom, commencing at 9:00 a.m. (London time) on 19 December 2023. The initial Adjourned Meeting (in respect of the Senior Secured Notes) will commence at 9:00 a.m. (London time), for the purposes of considering and, if thought fit, passing the Extraordinary Resolutions in respect of the proposed amendments with a subsequent Adjourned Meeting in respect of the Senior Unsecured Notes being held 10 minutes thereafter (or, if later, after the conclusion of the immediately preceding Meeting).

The quorum at each Adjourned Meeting pursuant to the Trust Deeds is one or more voters representing or holding not less than 33.33% of the aggregate principal amount of the relevant Notes. To be passed at each Adjourned Meeting pursuant to the Trust Deeds, the Extraordinary Resolutions require a majority in favour consisting of not less than 75% of the votes cast at the relevant Adjourned Meeting.

For the avoidance of doubt, the quorum and approval requirements under the Warrant Instrument at the relevant Meeting are lower than that required by the Trust Deeds. The quorum required by the Warrant Instrument at the Adjourned Meetings is at least 25% of the principal amount of the relevant Notes. To be passed at the Adjourned Meetings pursuant to the Warrant Instrument, the Extraordinary Resolutions require a majority in favour consisting of not less than 66.66% of the votes cast at the relevant Adjourned Meeting.

Noteholders submitting consent instructions will not be required to attend the Adjourned Meetings in person in order to vote, and the Information and Tabulation Agent will vote on their behalf in accordance with the consent instructions.

Questions from holders of Notes regarding the Consent Solicitation or requests for additional copies of the Consent Solicitation Memorandum should be directed to GLAS Trust Company LLC, the Information and Tabulation Agent for the Consent Solicitation, Telephone: +1 (201) 839-2200, Email contact with respect to the Consent Solicitation in respect of the Notes: TMGUS@glas.agency and clientservices.usadcm@glas.agency.

Under no circumstances shall the Consent Solicitation constitute an offer to sell or issue or the solicitation of an offer to buy or subscribe for any Notes in any jurisdiction.

Cautionary Statement

This notice is for informational purposes only and the Consent Solicitation are only being made pursuant to the terms of the Consent Solicitation Memorandum. The Consent Solicitation are not made, and consents are not being solicited from, holders of Notes in any jurisdiction in which it is unlawful to make such Consent Solicitation or grant such consent.

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
NRAFLFLIFILFLIV
Date   Source Headline
1st Jun 20267:00 amRNSPublication of Annual Report and Notice of AGM
26th May 20267:09 amRNS1st Quarter Results
14th May 202610:59 amRNSUpdate re Kazakhstan withholding tax disputes
7th May 20265:11 pmRNSBoard Change
30th Apr 20267:00 amRNSOperational Update for Q1 ended 31 March 2026
29th Apr 20267:00 amRNSFull Year Results
30th Mar 202611:38 amRNSProposed Transaction
17th Feb 202611:51 amRNSFurther update on Kazakhstan withholding tax
9th Feb 20269:17 amRNS-RUpdate re Kazakhstan withholding tax disputes
9th Feb 20267:00 amRNSBoard Committee Changes
3rd Feb 20269:38 amRNS-RUpdate on Kazakhstan withholding tax disputes
30th Jan 20267:00 amRNSOperational Update for Q4 and FY2025
26th Jan 202612:18 pmRNSBoard Change
2nd Jan 20268:30 amRNSNotice of delayed interest payments on notes
19th Dec 20255:02 pmRNSFurther statement in relation to AGM vote
19th Dec 20255:02 pmRNSFurther statement in relation to AGM vote
25th Nov 20257:00 amRNSFinancial results for Q3 and 9M 2025
21st Nov 20257:00 amRNSAppointment of NED and Board Committee Changes
31st Oct 202511:27 amRNSBoard Committee Change
31st Oct 20257:00 amRNSOperational Update for 3Q and 9M 2025
24th Oct 20257:00 amRNSAppointment of a NED and Board Committee Changes
17th Oct 20257:00 amRNSAppointment of Nikolay Ivin as Chairman
6th Oct 202510:57 amRNSConsent Solicitation Results
24th Sep 202510:02 amRNSConsent Solicitation
19th Sep 202512:38 pmRNSNew CFO
16th Sep 20254:35 pmRNSConsent solicitation results at early consent date
16th Sep 20253:40 pmRNSMaterial related party transaction and new COO
2nd Sep 20255:23 pmRNSConsent solicitation re payment delay on notes
29th Aug 20257:00 amRNSFinancial results for Q2 and 6M ended 30 June 2025
31st Jul 20257:00 amRNSOperational Update for Q2 and H1 2025
30th Jul 20259:19 amRNSUpdate: delayed interest payments,proposed actions
22nd Jul 20253:33 pmRNSUpdate: delayed interest payments,proposed actions
15th Jul 20255:37 pmRNSAppointment of CEO and a Non-Executive Director
10th Jul 202511:38 amRNSNotification of delayed interest payments
30th Jun 20251:48 pmRNSStakeholder discussions and Board changes
30th Jun 202512:18 pmRNSResult of AGM
6th Jun 202511:43 amRNSPublication of Annual Report and Notice of AGM
20th May 20257:00 amRNS1st Quarter Results
30th Apr 20257:00 amRNSOperational Update for Q1 2025
25th Apr 20253:25 pmRNS2024 Report on Payments to Governments
23rd Apr 20257:00 amRNSFull Year Results
10th Apr 20253:20 pmRNSTR-1: Notification of major holdings
7th Apr 20258:41 amRNSShares Cancellation, Change in Total Voting Rights
4th Apr 20257:00 amRNSApproval of Stepnoy Leopard Field Development Plan
21st Mar 20257:00 amRNSProcessing Agreement extension with Ural Oil & Gas
6th Feb 202511:52 amRNSHolding(s) in Company
31st Jan 20257:00 amRNSOperational Update for Q4 and FY2024
12th Dec 202412:01 pmRNSHolding(s) in Company
2nd Dec 20244:17 pmRNSPurchase and Cancellation of Deferred Shares
19th Nov 20247:00 amRNSFinancial Results for Q3 and 9M 2024

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.